On the left is a 3D rendering of enterovirus D68 (viral proteins red, yellow, blue) with human monoclonal antibody EV68-228 (orange/purple). To the right in the background is a colorized transmission electron micrograph of enterovirus D68 virus particles (green). 3D rendering by NIAID; micrograph, repositioned and recolored by NIAID, courtesy of CDC. Credit: CDC and NIAID
A NIAID-sponsored clinical trial has begun to evaluate the safety of an investigational monoclonal antibody to treat enterovirus D68 (EV-D68), which can cause severe respiratory and polio-like neurological disease – such as acute flaccid myelitis (AFM). Scientists are striving to better understand AFM, which has emerged in the United States with spikes in cases every other year, primarily in the late-summer months over the last decade. The U.S. Centers for Disease Control and Prevention (CDC) identified increases in AFM cases in 2014, 2016, and 2018. There are no Food and Drug Administration-approved treatments for severe EV-D68 infection or AFM. Clinical Trial NCT06444048 will enroll 36 healthy volunteers ages 18 to 49 at Vanderbilt University Medical Center and the University of Maryland.
This email was sent to myhcistech.healthnews360@blogger.com using GovDelivery Communications Cloud on behalf of: National Institute of Allergy and Infectious Diseases · 5601 Fishers Lane · Bethesda, MD 20892 · 1-866-284-4107
Many individuals with autism and their families use complementary health approaches, often along with conventional medical care, to address concerns and improve their health and well-being.
A variety of complementary approaches—such as animal-assisted therapy, arts-based therapies, yoga, acupuncture, massage therapy, and exercise-based therapies, may be helpful in treating hypersensitivity, reducing anxiety, and improving social skills and mental health in people with autism.
Low doses of melatonin may help with sleep problems in people with autism. Children with autism generally tolerate pediatric-appropriate prolonged-release melatonin well.
There's no scientific evidence that secretin, hyperbaric oxygen, chelation therapies, or antifungal agents can help people with autism.
This email was sent to myhcistech.healthnews360@blogger.com using GovDelivery Communications Cloud on behalf of: National Center for Complementary and Integrative Health · 9000 Rockville Pike · Bethesda, MD 20892
Get ready for Tour de Cure to make a difference for millions impacted by diabetes!
Dear Friend,
Over 38 million Americans have diabetes and one in five adults with diabetes don't know they have it. To improve the lives of EVERYONE affected by diabetes, we’re calling all riders to join us for Tour de Cure®, the premier cycling fundraising event of the American Diabetes Association® that creates diabetes awareness nationwide, funds lifesaving research, and brings us closer to our quest to find a cure.
You can pedal with purpose by participating in a Tour de Cure event happening in your area from now until October, or you can join us virtually from anywhere in the country for our nationwide event in September! Whether you ride as an individual or join a team of family, friends, or colleagues, your participation plays a significant role.
Your participation will help:
Support research to find better treatments and reduce severe complications from diabetes
Connect people living with diabetes and their caregivers to resources
Provide education about preventing or delaying the onset of diabetes
Fund critical, lifesaving research in our quest to find a cure
The more you raise, the more recognition you’ll receive and the more swag you’ll earn! Sign up today and raise at least $250 to earn an official event-day Tour de Cure T-shirt.
Friend, what are you waiting for? Diabetes hurts too many people and ends too many lives. Register to ride in Tour de Cure as we head toward a future free from diabetes and all its burdens.
National HIV Testing Day. Level up your self-love: Check your status. Credit: CDC
Today, NIAID joins our community and federal partners to observe the 29th National HIV Testing Day themed "Level up your self-love: check your status." This day is intended to empower people to access testing, learn their status, and get linked to HIV prevention or treatment services from which they could benefit, depending on their results. Research highlights the critical role pharmacists can play in HIV testing and related services. NIH-funded projects are identifying innovative models to leverage pharmacies for HIV testing, prevention, and care through partnerships between academic institutions and state and local leaders. The outcomes from current and future NIH-funded EHE pharmacy projects are being released through scientific channels to inform policy and practice
This email was sent to myhcistech.healthnews360@blogger.com using GovDelivery Communications Cloud on behalf of: National Institute of Allergy and Infectious Diseases · 5601 Fishers Lane · Bethesda, MD 20892 · 1-866-284-4107
